Sign In
Buy BMY
$56.60
+1.88 (+3.44%)
At Close: Jun 04, 2026
Wall Street's Most Accurate Analysts Say Hold These 3 Health Care Stocks With Over 3% Dividend Yields
09:04am, Monday, 29'th Jul 2024
During times of turbulence and uncertainty in the markets, even when markets are at all-time highs, many investors turn to dividend-yielding stocks.
This Bristol-Myers Squibb Analyst Turns Bearish; Here Are Top 5 Downgrades For Monday
08:32am, Monday, 29'th Jul 2024
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings pag
6 Blue Chip Dividend Stock Bargains to Buy Now That All Yield 5% and More
01:52pm, Sunday, 28'th Jul 2024
24/7 Wall St. Insights Dividend stocks will outperform when the Federal Reserve starts to lower rates in September.
Bristol Myers Squibb Shows Resilience Amid Patent Expiry Challenges (Rating Upgrade)
03:47am, Sunday, 28'th Jul 2024
Bristol Myers Squibb's Q2 2024 revenue increased 9% year-over-year, reaching $12.2 billion. Newer drugs like Reblozyl and Opdualag demonstrated strong revenue growth in Q2, 2024. Despite facing patent
2 High-Yield Dividend Stocks That Could Shine in 2025
11:15am, Saturday, 27'th Jul 2024
Dividend yields have historically been a strong predictor of stock returns over long periods. Current market conditions could be ripe for a rally in high-yield equities.
Bristol-Myers Squibb: Q2 Earnings Look Like An Inflection Point
08:29am, Saturday, 27'th Jul 2024
Bristol-Myers Squibb had a strong Q2 earnings report, backed by strong momentum in both legacy and new products. The management has boosted its guidance for the remainder of 2024, enhancing confidence
Why Bristol Myers Squibb Jumped Nearly 10% on Friday
01:35pm, Friday, 26'th Jul 2024
The drugmaker's newest therapies are seeing unexpectedly strong sales growth. Its legacy drug portfolio, meanwhile, is still a solid cash cow.
Bristol-Myers Squibb Company (BMY) Q2 2024 Earnings Call Transcript
01:15pm, Friday, 26'th Jul 2024
Bristol-Myers Squibb Company (NYSE:BMY ) Q2 2024 Earnings Conference Call July 26, 2024 8:00 AM ET Company Participants Tim Power - Vice President, Head of Investor Relations Chris Boerner - Board Cha
Stocks on the move: Bristol Myers, Abbive, and Tesla
01:11pm, Friday, 26'th Jul 2024
The Investment Committee discuss some of their stocks that are on the move today
Crude Oil Down Over 2%; Bristol Myers Squibb Posts Upbeat Q2 Results
12:02pm, Friday, 26'th Jul 2024
U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining over 100 points on Friday.
PCE/Core PCE Inflation In Line With Estimates in June
11:56am, Friday, 26'th Jul 2024
PCE/Core PCE Inflation In Line With Estimates in June.
Bristol-Myers (BMY) Tops on Q2 Earnings, Ups '24 EPS View
11:15am, Friday, 26'th Jul 2024
Bristol-Myers (BMY) posts impressive second-quarter results, with both earnings and sales beating their respective estimates. The company also raises its annual earnings guidance.
Bristol-Myers Squibb Beats Q2 Expectations, Boosts Guidance on Rising Drug Sales
10:46am, Friday, 26'th Jul 2024
Bristol-Myers Squibb (BMY) shares climbed Friday after the company beat expectations with its second-quarter results and raised its full-year guidance.
Bristol Myers (BMY) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates
10:36am, Friday, 26'th Jul 2024
While the top- and bottom-line numbers for Bristol Myers (BMY) give a sense of how the business performed in the quarter ended June 2024, it could be worth looking at how some of its key metrics compa
Bristol Myers Squibb (BMY) Q2 Earnings and Revenues Surpass Estimates
09:10am, Friday, 26'th Jul 2024
Bristol Myers Squibb (BMY) came out with quarterly earnings of $2.07 per share, beating the Zacks Consensus Estimate of $1.64 per share. This compares to earnings of $1.75 per share a year ago.
